North America Mycotoxin and Food Testing Market was valued at USD 410.7 million in 2021, growing at a high CAGR of 10.9% from 2022 to 2028 to reach USD 847.3 million by 2028. Food safety practices in the food sector have emerged due to rising consumer demand for fresh and acceptable food products. However, the high frequency of foodborne disease outbreaks in a number of countries, including wealthy ones like the United States, has prompted increased concern and rigorous research into foodborne pathogens. As a result, there is a higher demand for food microbiological testing. The goal of microbiological testing is to discover and limit the growth of dangerous bacteria that can cause food spoiling and hence assure foodborne disease safety. It is predicted to increase at a CAGR of 12.1%. Due to the growing prevalence of Fusarium graminearum species of fungi that produces DON toxin. The food segment, Cereals, grains, and pulses, has a significant market share and are expected to increase at a CAGR of 11.7% in the future years. Because cereals, grains, and pulses are utilized in various food processingÂ and food packaging equipment products, they are more sensitive to the co-occurrence of mycotoxins, resulting in a higher demand for testing. However, a Lack of awareness about the quantity required for mycotoxin testing, Lack of information in terms of sample standards hampers the Mycotoxin and Food Testing market.
Fastest Growing Market
Mycotoxin and Food Testing market is surging owing to frequent acquisitions and launchings by the market players. Strategic alliances by the players such as acquisitions, mergers, expansions and new product launches may enhance the companyâ€™s growth. In March 2019, SGS announced the expansion of its new food microbiological testing lab in Carson, California, US. The microbiological testing facility is 2,400 sq. ft. This expansion is aimed at broadening geographical coverage as well as its global network of agriculture and food laboratories.
The north america mycotoxin and food testing market is projected to expand at a CAGR of 10.9% during the forecast period
SGS SA, Eurofins Scientific SE, Alta Bioscience, Romer Labs Division Holding GmbH, Charm Sciences, Inc., Intertek Group plc., Trilogy Analytical LaboratoriesR-Biopharm AG, ELISA Technologies, Inc., EMSL Analytical, Inc., Belcosta Labs, Inc., ALS Limited